EPC EDGEWELL PERSONAL CARE Co
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1096752 · Fiscal year ends 09/30
Financial factors as of 2026-09-30 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.8%
TTM net income YoY-303.5%
TTM EPS YoY-311.3%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—
Margins
Gross margin41.6%
Operating margin2.1%
Net margin-2.6%
FCF margin-0.5%
EBITDA margin5.3%
Returns
ROE-3.4%
ROA-1.4%
ROIC (approx.)1.3%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets58.5%
Debt / equity0.85x
Current ratio1.82x
Interest coverage0.60x
Cash quality & payout
Operating cash flow / net income-0.96x
Accruals ratio-2.8%
Payout ratio—
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252026-09-30 | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 | FY20222022-09-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.00B | $1.96B | $1.97B | $2.25B | $2.17B |
| Cost of revenue | $1.17B | $1.11B | $1.12B | $1.31B | $1.29B |
| Gross profit | $830.00M | $847.80M | $854.00M | $940.80M | $880.50M |
| R&D expense | $57.50M | $55.60M | $56.40M | $58.50M | $55.50M |
| SG&A expense | $428.90M | $408.60M | $418.40M | $409.60M | — |
| Operating income | $41.40M | $110.20M | $133.30M | $227.00M | $182.30M |
| Interest expense | $68.90M | $73.20M | $76.50M | $78.50M | $71.40M |
| Pretax income | -$800,000 | $37.20M | $54.90M | $147.70M | $124.10M |
| Income tax | $1.40M | -$7.10M | $6.40M | $33.00M | $24.60M |
| Net income | -$51.70M | $25.40M | $98.60M | $114.70M | $99.50M |
| EBITDA | $119.20M | $199.00M | $221.30M | $318.40M | $272.20M |
| EPS (basic) | -1.12 | 0.53 | 1.98 | 2.24 | 1.87 |
| EPS (diluted) | -1.12 | 0.53 | 1.97 | 2.21 | 1.85 |
| Weighted avg. shares (diluted) | 46.30M | 47.60M | 50.10M | 51.80M | 53.60M |
| Balance sheet | |||||
| Cash & equivalents | $375.60M | $225.70M | $209.10M | $216.40M | $188.70M |
| Receivables | $132.40M | $137.80M | $109.40M | $106.20M | $136.90M |
| Inventory | $445.40M | $433.80M | $477.30M | $492.40M | $449.30M |
| Current assets | $1.12B | $995.50M | $936.00M | $962.40M | $942.20M |
| PP&E, net | $296.70M | $295.00M | $349.10M | $337.90M | $345.50M |
| Goodwill | $1.13B | $1.14B | $1.13B | $1.33B | $1.32B |
| Intangibles | $799.50M | $828.20M | $948.50M | $973.80M | $996.60M |
| Total assets | $3.55B | $3.76B | $3.73B | $3.74B | $3.71B |
| Current liabilities | $616.00M | $565.50M | $563.60M | $523.40M | $539.50M |
| Short-term debt | — | — | — | — | $0 |
| Long-term debt | $1.25B | $1.38B | $1.27B | $1.36B | $1.39B |
| Total debt | $1.25B | $1.38B | $1.27B | $1.36B | $1.39B |
| Total liabilities | $2.08B | $2.20B | $2.15B | $2.20B | $2.25B |
| Shareholders' equity | $1.47B | $1.55B | $1.58B | $1.54B | $1.47B |
| Net debt | $869.90M | $1.16B | $1.07B | $1.14B | $1.20B |
| Shares outstanding | 46.09M | 46.46M | 48.92M | 50.12M | 51.57M |
| Cash flow statement | |||||
| Operating cash flow | $49.60M | $118.40M | $231.00M | -$216.10M | $102.00M |
| Capital expenditure | $59.60M | $77.00M | $56.50M | $49.50M | $56.40M |
| Free cash flow | -$10.00M | $41.40M | $174.50M | -$265.60M | $45.60M |
| Investing cash flow | $289.20M | -$72.90M | -$62.40M | -$50.50M | -$355.40M |
| Financing cash flow | -$182.80M | -$30.00M | -$179.40M | -$146.50M | -$17.60M |
| Depreciation & amortization | $77.80M | $88.80M | $88.00M | $91.40M | $89.90M |
| Stock-based compensation | $19.00M | $24.50M | $26.50M | $27.50M | $23.80M |
| Dividends paid | $28.40M | $29.30M | $30.70M | $31.50M | $32.60M |
| Share buybacks | $15.80M | $90.20M | $58.50M | $75.20M | $125.30M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.